Cargando…
Decomposing compounds enables reconstruction of interaction fingerprints for structure-based drug screening
BACKGROUND: Structure-based drug repositioning has emerged as a promising alternative to conventional drug development. Regardless of the many success stories reported over the past years and the novel breakthroughs on the AI-based system AlphaFold for structure prediction, the availability of struc...
Autores principales: | Adasme, Melissa F., Bolz, Sarah Naomi, Al-Fatlawi, Ali, Schroeder, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8922937/ https://www.ncbi.nlm.nih.gov/pubmed/35292113 http://dx.doi.org/10.1186/s13321-022-00592-w |
Ejemplares similares
-
Drug repositioning or target repositioning: A structural perspective of drug-target-indication relationship for available repurposed drugs
por: Parisi, Daniele, et al.
Publicado: (2020) -
PLIP 2021: expanding the scope of the protein–ligand interaction profiler to DNA and RNA
por: Adasme, Melissa F, et al.
Publicado: (2021) -
Historeceptomic Fingerprints for Drug-Like Compounds
por: Shmelkov, Evgeny, et al.
Publicado: (2015) -
Repositioned Drugs for Chagas Disease Unveiled via Structure-Based Drug Repositioning
por: Adasme, Melissa F., et al.
Publicado: (2020) -
From malaria to cancer: Computational drug repositioning of amodiaquine using PLIP interaction patterns
por: Salentin, Sebastian, et al.
Publicado: (2017)